Skip to main content

Global Recombinant Plasma Proteins market cagr 11.5%

Page 1


Recombinant Plasma Proteins Market

Recombinant Plasma Proteins Market Scope:

Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Recombinant Plasma Proteins Market Size and Growth

The Recombinant Plasma Proteins market is witnessing significant growth, driven by rising demand for advanced therapeutic solutions. The market, valued at approximately $10 billion in 2023, is projected to expand at a robust CAGR due to innovations in biotechnology, increasing incidences of rare diseases, and enhanced governmental support for biologics. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ CSL Limited

◍ Shire (Takeda Pharmaceutical Company Limited)

◍ Octapharma

◍ Novo Nordisk

◍ Bayer

◍ Bioverativ Therapeutics, Inc. (Sanofi)

◍ Aptevo Therapeutics

◍ Pharming Group

◍ Pfizer

The Recombinant Plasma Proteins Market features major players like CSL Limited, Shire (Takeda), Octapharma, and Novo Nordisk, driving growth through innovative therapies and expanding product portfolios. Companies generate significant revenue by addressing unmet medical needs in hemophilia and coagulation disorders, boosting market share through strategic collaborations and R&D investments.

Request Sample Report

Market Segmentation

By Application

Hemophilia A

Hemophilia B

Von Willebrand Disease

Others Request Sample Report

By Product

Chinese Hamster Ovary (CHO) Cell Line

Baby Hamster Kidney (BHK) Cell Line

Human Embryonic Kidney (HEK) Cell Line

Others

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook